The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy

BACKGROUND: Patients with hereditary transthyretin amyloidosis (ATTRv) frequently experience symptoms of polyneuropathy (PN) that worsen over time and impair daily functioning. Previous analyses supported efficacy of inotersen, an antisense oligonucleotide, to slow neuropathic progression in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Yarlas, Aaron, Lovley, Andrew, Brown, Duncan, Vera-Llonch, Montserrat, Khella, Sami, Karam, Chafic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022100/
https://www.ncbi.nlm.nih.gov/pubmed/36932361
http://dx.doi.org/10.1186/s12883-023-03116-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022100/
https://www.ncbi.nlm.nih.gov/pubmed/36932361
http://dx.doi.org/10.1186/s12883-023-03116-7

Ejemplares similares